Responding to the surge of substandard and falsified health products triggered by the Covid-19 pandemic

By Nagesh N. Borse, June Cha, Christina G. Chase, Raashi Gaur, et al.

Substandard and falsified medical products such as vaccines and medicines are a serious and growing global health issue1 . Other health products such as diagnostic kits and infection preventatives, including but not limited to masks and hand sanitizers, are also found on the market in substandard and falsified versions, as discussed below. In this article, the authors refer to all of these products as substandard and falsified health products (SFHP).* COVID-19, like previous pandemics, has increased the vulnerability of global supply chains to SFHP. This paper explores the basics of SFHP, reviews what we have learned from past pandemics, and offers a perspective on existing and needed tools to protect health products, and the people who use them, from the threat of SFHP.

Washington, DC: USP, 2021. 11p.